Health Catalyst, Inc. 8-K

What Happened Health Catalyst, Inc. (HCAT) filed an 8-K confirming that CEO Daniel Burton accelerated his retirement effective February 12, 2026 and, under a Transition Agreement dated March 31, 2026, has agreed to remain employed as a strategic advisor through December 31, 2026. The company previously disclosed the retirement acceleration in a Form 8-K filed February 18, 2026.

Key Details

• Daniel Burton’s retirement as CEO became effective February 12, 2026; Transition Agreement executed March 31, 2026.
• Burton will serve as an employee with the title "strategic advisor" through December 31, 2026.
• He will receive an average monthly base salary of $10,000 beginning March 1, 2026.
• As part of the agreement, Burton forfeited all of his unvested restricted stock units and any unvested performance-based restricted stock units eligible to vest after March 2, 2026, and provided a general release of claims against the company.

Why It Matters This filing confirms the company’s plan for leadership transition and the terms for the former CEO’s continued advisory role. The forfeiture of unvested equity reduces future potential dilution tied to Burton’s awards, while his advisory role (at $10,000/month) provides temporary continuity at modest cost. Investors should note the dates and equity forfeiture terms when assessing management changes and any related governance or compensation impacts.